Krabbe Disease in the Arab World

Abstract

The autosomal recessive inherited Krabbe disease (KD) is a devastating pediatric lysosomal storage disorder affecting white matter of the brain. It is caused by mutations in the gene coding for the lysosomal enzyme galactocerebrosidase. While most patients present with symptoms within the first 6 months of life, others present later in life throughout adulthood. The early infantile form of KD (EIKD) is frequent in the Muslim Arab population in Israel, with a very high prevalence of approximately 1/100 to 1/150 live births. The homozygous variant c.1582G > A (p.D528N) was found to be responsible for EIKD in Palestinian Arab patients. KD was reported in different Arab countries with much lower frequency. While most Arab patients presented with EIKD, late infantile and late onset KD forms were also reported. Most Arab patients presented with variable symptoms ranging from EIKD to late onset KD, with variable clinical findings. Based on literature studies, this review focuses on the clinical and molecular findings of KD patients with Arab ancestry, and highlights the need for developing universal genetic screening programs to overcome the under-reported status of KD prevalence in Arabia. This is expected to improve the prognosis of the disease and promote targeted molecular diagnostics to the Arab patients.

Keywords

Krabbe disease - galactocerebrosidase - genotype–phenotype correlation - Arabs - prenatal diagnosis

• References

• 1 Suzuki K. Globoid cell leukodystrophy (Krabbe's disease): update. J Child Neurol 2003; 18 (9) 595-603
• 2 Poupetová H, Ledvinová J, Berná L, Dvoráková L, Kozich V, Elleder M. The birth prevalence of lysosomal storage disorders in the Czech Republic: comparison with data in different populations. J Inherit Metab Dis 2010; 33 (4) 387-396
• 3 Zlotogora J, Regev R, Zeigler M, Iancu TC, Bach G. Krabbe disease: increased incidence in a highly inbred community. Am J Med Genet 1985; 21 (4) 765-770
• 4 Barczykowski AL, Foss AH, Duffner PK, Yan L, Carter RL. Death rates in the U.S. due to Krabbe disease and related leukodystrophy and lysosomal storage diseases. Am J Med Genet A 2012; 158A (11) 2835-2842
• 5 Fiumara A, Barone R, Arena A , et al. Krabbe leukodystrophy in a selected population with high rate of late onset forms: longer survival linked to c.121G>A (p.Gly41Ser) mutation. Clin Genet 2011; 80 (5) 452-458
• 6 Korn-Lubetzki I, Dor-Wollman T, Soffer D, Raas-Rothschild A, Hurvitz H, Nevo Y. Early peripheral nervous system manifestations of infantile Krabbe disease. Pediatr Neurol 2003; 28 (2) 115-118
• 7 Wenger DA, Rafi MA, Luzi P. Molecular genetics of Krabbe disease (globoid cell leukodystrophy): diagnostic and clinical implications. Hum Mutat 1997; 10 (4) 268-279
• 8 Wenger DA, Rafi MA, Luzi P, Datto J, Costantino-Ceccarini E. Krabbe disease: genetic aspects and progress toward therapy. Mol Genet Metab 2000; 70 (1) 1-9
• 9 Yang Y, Ren X, Xu Q, Wang C, Liu H, He X. Four novel GALC gene mutations in two Chinese patients with Krabbe disease. Gene 2013; 519 (2) 381-384
• 10 Barone R, Brühl K, Stoeter P, Fiumara A, Pavone L, Beck M. Clinical and neuroradiological findings in classic infantile and late-onset globoid-cell leukodystrophy (Krabbe disease). Am J Med Genet 1996; 63 (1) 209-217
• 11 Hagberg B, Kollberg H, Sourander P, Akesson HO. Infantile globoid cell leucodystrophy (Krabbe's disease). A clinical and genetic study of 32 Swedish cases 1953–1967. Neuropadiatrie 1969; 1 (1) 74-88
• 12 Puckett RL, Orsini JJ, Pastores GM , et al. Krabbe disease: clinical, biochemical and molecular information on six new patients and successful retrospective diagnosis using stored newborn screening cards. Mol Genet Metab 2012; 105 (1) 126-131
• 13 Duffner PK, Barczykowski A, Kay DM , et al. Later onset phenotypes of Krabbe disease: results of the world-wide registry. Pediatr Neurol 2012; 46 (5) 298-306
• 14 Goebel HH, Harzer K, Ernst JP, Bohl J, Klein H. Late-onset globoid cell leukodystrophy: unusual ultrastructural pathology and subtotal beta-galactocerebrosidase deficiency. J Child Neurol 1990; 5 (4) 299-307
• 15 Kolodny EH, Raghavan S, Krivit W. Late-onset Krabbe disease (globoid cell leukodystrophy): clinical and biochemical features of 15 cases. Dev Neurosci 1991; 13 (4-5) 232-239
• 16 Luzi P, Rafi MA, Wenger DA. Multiple mutations in the GALC gene in a patient with adult-onset Krabbe disease. Ann Neurol 1996; 40 (1) 116-119
• 17 Phelps M, Aicardi J, Vanier MT. Late onset Krabbe's leukodystrophy: a report of four cases. J Neurol Neurosurg Psychiatry 1991; 54 (4) 293-296
• 18 Thomas PK, Halpern JP, King RH, Patrick D. Galactosylceramide lipidosis: novel presentation as a slowly progressive spinocerebellar degeneration. Ann Neurol 1984; 16 (5) 618-620
• 19 Turazzini M, Beltramello A, Bassi R, Del Colle R, Silvestri M. Adult onset Krabbe's leukodystrophy: a report of 2 cases. Acta Neurol Scand 1997; 96 (6) 413-415
• 20 Debs R, Froissart R, Aubourg P , et al. Krabbe disease in adults: phenotypic and genotypic update from a series of 11 cases and a review. J Inherit Metab Dis 2013; 36 (5) 859-868
• 21 Lyon G, Hagberg B, Evrard P, Allaire C, Pavone L, Vanier M. Symptomatology of late onset Krabbe's leukodystrophy: the European experience. Dev Neurosci 1991; 13 (4-5) 240-244
• 22 Oehlmann R, Zlotogora J, Wenger DA, Knowlton RG. Localization of the Krabbe disease gene (GALC) on chromosome 14 by multipoint linkage analysis. Am J Hum Genet 1993; 53 (6) 1250-1255
• 23 Chen YQ, Rafi MA, de Gala G, Wenger DA. Cloning and expression of cDNA encoding human galactocerebrosidase, the enzyme deficient in globoid cell leukodystrophy. Hum Mol Genet 1993; 2 (11) 1841-1845
• 24 Sakai N, Inui K, Fujii N , et al. Krabbe disease: isolation and characterization of a full-length cDNA for human galactocerebrosidase. Biochem Biophys Res Commun 1994; 198 (2) 485-491
• 25 Chen YQ, Wenger DA. Galactocerebrosidase from human urine: purification and partial characterization. Biochim Biophys Acta 1993; 1170 (1) 53-61
• 26 Human Gene Mutation Database (HGMD) Available at: http://www.hgmd.org . Accessed December 4, 2014
• 27 NHLBI Exome Sequence Project of the Exome Variant Server available at: http://evs.gs.washington.edu/EVS . Accessed November 29, 2014
• 28 Kleijer WJ, Keulemans JL, van der Kraan M , et al. Prevalent mutations in the GALC gene of patients with Krabbe disease of Dutch and other European origin. J Inherit Metab Dis 1997; 20 (4) 587-594
• 29 Xu C, Sakai N, Taniike M, Inui K, Ozono K. Six novel mutations detected in the GALC gene in 17 Japanese patients with Krabbe disease, and new genotype-phenotype correlation. J Hum Genet 2006; 51 (6) 548-554
• 30 Liao P, Gelinas J, Sirrs S. Phenotypic variability of Krabbe disease across the lifespan. Can J Neurol Sci 2014; 41 (1) 5-12
• 31 Rafi MA, Luzi P, Zlotogora J, Wenger DA. Two different mutations are responsible for Krabbe disease in the Druze and Moslem Arab populations in Israel. Hum Genet 1996; 97 (3) 304-308
• 32 Zlotogora J, Levy-Lahad E, Legum C, Iancu TC, Zeigler M, Bach G. Krabbe disease in Israel. Isr J Med Sci 1991; 27 (4) 196-198
• 33 Graziano AC, Cardile V. History, genetic, and recent advances on Krabbe disease. Gene 2015; 555 (1) 2-13
• 34 Nagano S, Yamada T, Shinnoh N, Furuya H, Taniwaki T, Kira J. Expression and processing of recombinant human galactosylceramidase. Clin Chim Acta 1998; 276 (1) 53-61
• 35 Deane JE, Graham SC, Kim NN , et al. Insights into Krabbe disease from structures of galactocerebrosidase. Proc Natl Acad Sci U S A 2011; 108 (37) 15169-15173
• 36 Wiederschain G, Raghavan S, Kolodny E. Characterization of 6-hexadecanoylamino-4-methylumbelliferyl-beta-D- galactopyranoside as fluorogenic substrate of galactocerebrosidase for the diagnosis of Krabbe disease. Clin Chim Acta 1992; 205 (1-2) 87-96
• 37 Li Y, Brockmann K, Turecek F, Scott CR, Gelb MH. Tandem mass spectrometry for the direct assay of enzymes in dried blood spots: application to newborn screening for Krabbe disease. Clin Chem 2004; 50 (3) 638-640
• 38 Wenger D. Krabbe disease. In: Pagon RA, Adam MP, Ardinger HH, Bird TD, Dolan CR, Fong CT, Smith RJH, Stephens K, , eds. GeneReviews. Available at: http://www.ncbi.nlm.nih.gov/books/NBK1238/ . Accessed December 3, 2014
• 39 Tappino B, Biancheri R, Mort M , et al. Identification and characterization of 15 novel GALC gene mutations causing Krabbe disease. Hum Mutat 2010; 31 (12) E1894-E1914
• 40 De Gasperi R, Gama Sosa MA, Sartorato EL , et al. Molecular heterogeneity of late-onset forms of globoid-cell leukodystrophy. Am J Hum Genet 1996; 59 (6) 1233-1242
• 41 Lissens W, Arena A, Seneca S , et al. A single mutation in the GALC gene is responsible for the majority of late onset Krabbe disease patients in the Catania (Sicily, Italy) region. Hum Mutat 2007; 28 (7) 742
• 42 Husain AM, Altuwaijri M, Aldosari M. Krabbe disease: neurophysiologic studies and MRI correlations. Neurology 2004; 63 (4) 617-620
• 43 Siddiqi ZA, Sanders DB, Massey JM. Peripheral neuropathy in Krabbe disease: effect of hematopoietic stem cell transplantation. Neurology 2006; 67 (2) 268-272
• 44 Hossain MA, Otomo T, Saito S , et al. Late-onset Krabbe disease is predominant in Japan and its mutant precursor protein undergoes more effective processing than the infantile-onset form. Gene 2014; 534 (2) 144-154
• 45 Fu L, Inui K, Nishigaki T , et al. Molecular heterogeneity of Krabbe disease. J Inherit Metab Dis 1999; 22 (2) 155-162
• 46 Furuya H, Kukita Y, Nagano S , et al. Adult onset globoid cell leukodystrophy (Krabbe disease): analysis of galactosylceramidase cDNA from four Japanese patients. Hum Genet 1997; 100 (3-4) 450-456
• 47 Tatsumi N, Inui K, Sakai N , et al. Molecular defects in Krabbe disease. Hum Mol Genet 1995; 4 (10) 1865-1868
• 48 Svennerholm L, Vanier MT, Månsson JE. Krabbe disease: a galactosylsphingosine (psychosine) lipidosis. J Lipid Res 1980; 21 (1) 53-64
• 49 Vanier M, Svennerholm L. Chemical pathology of Krabbe disease: the occurrence of psychosine and other neutral sphingoglycolipids. Adv Exp Med Biol 1976; 68: 115-126
• 50 Zhu H, Lopez-Rosas A, Qiu X, Van Breemen RB, Bongarzone ER. Detection of the neurotoxin psychosine in samples of peripheral blood: application in diagnostics and follow-up of Krabbe disease. Arch Pathol Lab Med 2012; 136 (7) 709-710
• 51 Harzer K, Knoblich R, Rolfs A, Bauer P, Eggers J. Residual galactosylsphingosine (psychosine) beta-galactosidase activities and associated GALC mutations in late and very late onset Krabbe disease. Clin Chim Acta 2002; 317 (1-2) 77-84
• 52 Radin NS, Arora RC. A simplified assay method for galactosyl ceramide beta-galactosidase. J Lipid Res 1971; 12 (2) 256-257
• 53 Tadmouri GO, Nair P, Obeid T, Al Ali MT, Al Khaja N, Hamamy HA. Consanguinity and reproductive health among Arabs. Reprod Health 2009; 6: 17
• 54 Al-Gazali L, Hamamy H, Al-Arrayad S. Genetic disorders in the Arab world. BMJ 2006; 333 (7573) 831-834
• 55 Macarov M, Zlotogora J, Meiner V , et al. Genetic screening for Krabbe disease: learning from the past and looking to the future. Am J Med Genet A 2011; 155A (3) 574-576
• 56 Jaber L, Dolfin T, Shohat T, Halpern GJ, Reish O, Fejgin M. Prenatal diagnosis for detecting congenital malformations: acceptance among Israeli Arab women. Isr Med Assoc J 2000; 2 (5) 346-350
• 57 Foss AH, Duffner PK, Carter RL. Lifetime risk estimators in epidemiological studies of Krabbe Disease: Review and Monte Carlo comparison. Rare Dis 2013; 1: e25212
• 58 Beiser A, D'Agostino Sr RB, Seshadri S, Sullivan LM, Wolf PA. Computing estimates of incidence, including lifetime risk: Alzheimer's disease in the Framingham Study. The Practical Incidence Estimators (PIE) macro. Stat Med 2000; 19 (11-12) 1495-1522
• 59 Freundlich E, Hino N. Consanguineous marriage among rural Arabs in Israel. Isr J Med Sci 1984; 20 (11) 1035-1038
• 60 Tirosh E, Schnitzer MR, Atar S, Jaffe M. Severe visual deficits in infancy in northern Israel: an epidemiological perspective. J Pediatr Ophthalmol Strabismus 1992; 29 (6) 366-369
• 61 Zlotogora J. Autosomal recessive diseases among Palestinian Arabs. J Med Genet 1997; 34 (9) 765-766
• 62 Lee WC, Kang D, Causevic E, Herdt AR, Eckman EA, Eckman CB. Molecular characterization of mutations that cause globoid cell leukodystrophy and pharmacological rescue using small molecule chemical chaperones. J Neurosci 2010; 30 (16) 5489-5497
• 63 Zlotogora J, Reshef N. Prenatal testing for genetic disorders among Arabs. Prenat Diagn 1998; 18 (3) 219-224
• 64 Al-Essa MA, Bakheet SM, Patay ZJ, Powe JE, Ozand PT. Clinical and cerebral FDG PET scan in a patient with Krabbe's disease. Pediatr Neurol 2000; 22 (1) 44-47
• 65 al Talabani J, Shubbar AI, Mustafa KE. Major congenital malformations in United Arab Emirates (UAE): need for genetic counselling. Ann Hum Genet 1998; 62 (Pt 5) 411-418
• 66 Szymańska K, Ługowska A, Laure-Kamionowska M , et al. Diagnostic difficulties in Krabbe disease: a report of two cases and review of literature. Folia Neuropathol 2012; 50 (4) 346-356
• 67 Kardas F, Uzak AS, Hossain MA, Sakai N, Canpolat M, Yıkılmaz A. A novel homozygous GALC mutation: very early onset and rapidly progressive Krabbe disease. Gene 2013; 517 (1) 125-127
• 68 Hathout H. Islamic views on some reproductive issues. In: Teebi AS, Farag TI, , editors. Genetic disorders among Arab populations, Oxford Mono graphs on Medical Genetics, No. 30. New York: Oxford University Press; 1997: 469-473
• 69 Swinford A, El-Fouly M. Islamic religion and culture: principles and applications for genetic counseling. In: Biesecker B, Magyari AP, Paul NW, , eds. Strategies in genetic counseling, birth defect. Michigan: Michigan State University; 1987: 253-256
• 70 Jardim LB, Giugliani R, Pires RF , et al. Protracted course of Krabbe disease in an adult patient bearing a novel mutation. Arch Neurol 1999; 56 (8) 1014-1017